Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 355

1.

Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.

Davidson JR, Bose A, Wang Q.

J Clin Psychiatry. 2005 Nov;66(11):1441-6.

PMID:
16420082
2.

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.

Davidson JR, Bose A, Korotzer A, Zheng H.

Depress Anxiety. 2004;19(4):234-40.

PMID:
15274172
3.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
4.

A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.

Montgomery SA, Nil R, Dürr-Pal N, Loft H, Boulenger JP.

J Clin Psychiatry. 2005 Oct;66(10):1270-8.

PMID:
16259540
5.

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

Mohamed S, Osatuke K, Aslam M, Kasckow J.

Am J Geriatr Pharmacother. 2006 Sep;4(3):201-9.

PMID:
17062320
6.
7.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
8.
9.

A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder.

Bielski RJ, Bose A, Chang CC.

Ann Clin Psychiatry. 2005 Apr-Jun;17(2):65-9.

PMID:
16075658
10.

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.

Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.

Arch Gen Psychiatry. 2008 May;65(5):551-62. doi: 10.1001/archpsyc.65.5.551.

PMID:
18458207
11.
12.

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

Burke WJ, Gergel I, Bose A.

J Clin Psychiatry. 2002 Apr;63(4):331-6.

PMID:
12000207
14.
15.

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

Stahl SM, Gergel I, Li D.

J Clin Psychiatry. 2003 Nov;64(11):1322-7.

PMID:
14658946
16.

The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.

Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K.

J Clin Psychiatry. 2005 Nov;66(11):1401-8.

PMID:
16420077
17.

Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.

J Clin Psychiatry. 2006 Oct;67(10):1522-6.

PMID:
17107242
18.
19.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753
20.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525

Supplemental Content

Support Center